| Item Type | Name |
|
Academic Article
|
New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.
|
|
Academic Article
|
Infant temperament and high-risk environment relate to behavior problems and language in toddlers.
|
|
Academic Article
|
Modafinil for the treatment of methamphetamine dependence.
|
|
Academic Article
|
Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.
|
|
Academic Article
|
Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.
|
|
Academic Article
|
Health conditions in methamphetamine-dependent adults 3 years after treatment.
|
|
Academic Article
|
The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age.
|
|
Academic Article
|
Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.
|
|
Academic Article
|
Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis.
|
|
Academic Article
|
Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine.
|
|
Academic Article
|
Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.
|
|
Academic Article
|
Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users.
|
|
Academic Article
|
Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study.
|
|
Academic Article
|
Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study.
|
|
Academic Article
|
Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction.
|
|
Academic Article
|
Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.
|
|
Academic Article
|
Stimulant Use Disorders.
|
|
Academic Article
|
Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study.
|
|
Academic Article
|
The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.
|
|
Academic Article
|
Electrocardiographic abnormalities in methamphetamine abusers.
|
|
Academic Article
|
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
|
|
Academic Article
|
Prenatal methamphetamine use and neonatal neurobehavioral outcome.
|
|
Academic Article
|
Association between psychiatric symptoms and craving in methamphetamine users.
|
|
Academic Article
|
Novel biomarkers of prenatal methamphetamine exposure in human meconium.
|
|
Academic Article
|
Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL).
|
|
Academic Article
|
Bupropion for the treatment of methamphetamine dependence.
|
|
Academic Article
|
Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine.
|
|
Concept
|
Methamphetamine
|